Budipine is a synthetic pharmaceutical chemical (CAS: 5369-56-4) primarily used in the treatment of Parkinson's disease. It helps manage symptoms such as tremors, stiffness, and slow movement by influencing neurotransmitter activity in the brain, particularly through modulation of NMDA receptors affecting dopamine and glutamate systems. The compound is often employed as an adjunct therapy, especially when other medications like levodopa are not fully effective, providing symptomatic relief and addressing motor fluctuations and dyskinesias associated with long-term Parkinson's treatment. However, its use is carefully monitored due to potential side effects, including dizziness and dry mouth.